Providing the broad range of allergy patients with treatment options that meet their individual needs is the basis for the La Crosse Method™ Practice Protocol, the most widely-used SLIT protocol in the U.S. The La Crosse Method is intended to offer practitioners with a safe, effective option for the full spectrum of allergic patients — from those who are moderately allergic to those whose allergies have become debilitating and ultimately life-threatening.
A combination of one or more La Crosse Method sublingual immunotherapy protocols may be offered to patients based on patient history, symptoms and the number and severity of allergies. Treatment options include:
When considering the appropriate protocol, special consideration should be given to what will ensure the highest level of safety for the patient given his or her history, exam and allergy testing results, i.e. what will offer the maximum benefits with minimal risk. Based on clinical evidence and current scientific research, optimal dosing levels are based on what is therapeutically effective for each individual patient and adjusted accordingly throughout the treatment course.
Because our dose escalation is supported by retesting and monitoring patient response; it minimizes risks of unnecessarily high doses without incremental benefit or adverse events, while simultaneously avoiding a dosing scenario that becomes cost-prohibitive for patients.